Bank of Montreal
SWTX

Bank of Montreal’s SpringWorks Therapeutics SWTX Stock Holding History

Bank of Montreal’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14,685
Closed -$757K – 4227
2024
Q1 		$757K Buy
+14,685
New +$679K ﹤0.01% 2171
2022
Q3 		– Sell
-30,948
Closed -$785 – 4398
2022
Q2 		$785 Buy
+30,948
New +$1.13M ﹤0.01% 2457
2021
Q4 		– Sell
-6,507
Closed -$450K – 3860
2021
Q3 		$450K Sell
6,507
-110,764
-94% -$8.54M ﹤0.01% 2934
2021
Q2 		$9.75M Buy
117,271
+116,323
+12,270% +$8.83M ﹤0.01% 1281
2021
Q1 		$68K Sell
948
-2,805
-75% -$220K ﹤0.01% 3575
2020
Q4 		$247K Buy
3,753
+2,693
+254% +$173K ﹤0.01% 3113
2020
Q3 		$55K Sell
1,060
-715
-40% -$30.4K ﹤0.01% 3392
2020
Q2 		$70K Buy
+1,775
New +$63.2K ﹤0.01% 3260
2020
Q1 		– Sell
-1,312
Closed -$50K – 4672
2019
Q4 		$50K Buy
+1,312
New +$30.7K ﹤0.01% 3837

Other funds holding SWTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Bank of Montreal's SWTX Position: Q2 2024 in Review

Bank of Montreal sold out of SpringWorks Therapeutics (SWTX) in Q2 2024, closing a stake of 14,685 shares — an estimated $757K sold.

Bank of Montreal first reported a position in SWTX in Q4 2019 and held it in 9 quarters. The position peaked at $9.75M in Q2 2021. 209 funds tracked by Wall St. Rank hold SWTX as of Q2 2024.

  • Bank of Montreal reported no remaining SpringWorks Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Bank of Montreal sold 14,685 SpringWorks Therapeutics shares in Q2 2024, an estimated $757K.
  • Bank of Montreal first reported a position in SpringWorks Therapeutics in Q4 2019 and held it in 9 quarters.
  • Bank of Montreal's SpringWorks Therapeutics position peaked at $9.75M in Q2 2021.
  • 209 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2024.

Based on Bank of Montreal's 13F filing for Q2 2024, filed 14 Aug 2024.